On April 21, 2022, Statera Biopharma, Inc. (the Company) accepted the resignation of Cozette M. McAvoy, Chief Legal Officer effective as of April 30, 2022. Her decision was not a result of any disagreement with the Company or its Board of Directors or any matter relating to the Company's operations, policies or practices. Following her resignation, Ms. McAvoy will become an Advisor to the Board of Directors of the Company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0007 USD | 0.00% | 0.00% | +16.67% |
2023 | Statera Biopharma, Inc. entered into a letter of intent to acquire Worksite Labs. | CI |
2023 | Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
+16.67% | 50.81K | |
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- STAB Stock
- News Statera Biopharma, Inc.
- Statera Biopharma, Inc. Resignation Cozette M. McAvoy, Chief Legal Officer